Share on Facebook
Share on Twitter
Share on LinkedIn

Medtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 (BMP-2) product, Infuse, and that many more lawsuits may be coming.

In addition, several states now are looking into sales and marketing practices involving Infuse, which is used in spine surgery.

Click here to read more.